CHANGES IN LUNG FUNCTION IN THE TREATMENT OF PATIENTS WITH EXOGENOUS ALLERGIC ALVEOLITIS

Total lung capacity (TLC), lung capacity (LC), forced LC (FLC), intrathoracic volume (ITV), pulmonary residual volume (PRV), forced expiratory volume in one second (FEV1 ), (FEV1 )/LC%, peak expiratory flow (PEF), maximum expiratory flow rate (MEFR)25, MEFR50, MEFR75, Raw, Rin, Rex, DLCO-SB, DLCO-SB...

Full description

Saved in:
Bibliographic Details
Main Authors: V. B. Nefedov, L. A. Popova, E. A. Shergina, N. N. Makaryants
Format: Article
Language:Russian
Published: New Terra Publishing House 2014-10-01
Series:Туберкулез и болезни лёгких
Subjects:
Online Access:https://www.tibl-journal.com/jour/article/view/291
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850284521588523008
author V. B. Nefedov
L. A. Popova
E. A. Shergina
N. N. Makaryants
author_facet V. B. Nefedov
L. A. Popova
E. A. Shergina
N. N. Makaryants
author_sort V. B. Nefedov
collection DOAJ
description Total lung capacity (TLC), lung capacity (LC), forced LC (FLC), intrathoracic volume (ITV), pulmonary residual volume (PRV), forced expiratory volume in one second (FEV1 ), (FEV1 )/LC%, peak expiratory flow (PEF), maximum expiratory flow rate (MEFR)25, MEFR50, MEFR75, Raw, Rin, Rex, DLCO-SB, DLCO-SB/VА, РаО2 , and РаСО2 were determined in 43 patients with exogenous allergic alveolitis (EAA) before, during, and after treatment with glucocorticosteroids, hemapheresis, ambroxol, and fluimucil. Lung function became better in more than half (53.5%) of the patients and worse in one fourth (25.6%); a combination of positive and negative functional changes was detected in 14.0%. Improved lung function was noted in 75.0, 50.0, and 38.5% of the patients with acute, subacute, and chronic EAA, respectively. Deterioration of lung function was determined in 46.2, 22.2, and 8.3% of the patients with chronic, subacute, and acute alveolitis, respectively. Better lung function manifested itself mainly as positive changes in lung volumes and capacities and pulmonary gas exchange function, less frequently as improved bronchial patency in the patients with acute and subacute EAA whereas the rate of positive functional changes in lung volumes and capacities, bronchial patency, and pulmonary gas exchange function was equal in those with chronic EAA. Poorer lung function appeared as negative changes in lung volumes and capacities in the patients with acute EAA, as worse pulmonary gas exchange function and negative changes in lung volumes and capacities and deteriorated bronchial patency in those with subacute and chronic EAA.
format Article
id doaj-art-0f03c80d23c349a284713ddcc64cd5b1
institution OA Journals
issn 2075-1230
2542-1506
language Russian
publishDate 2014-10-01
publisher New Terra Publishing House
record_format Article
series Туберкулез и болезни лёгких
spelling doaj-art-0f03c80d23c349a284713ddcc64cd5b12025-08-20T01:47:33ZrusNew Terra Publishing HouseТуберкулез и болезни лёгких2075-12302542-15062014-10-01010434910.21292/2075-1230-2014-0-10-43-49291CHANGES IN LUNG FUNCTION IN THE TREATMENT OF PATIENTS WITH EXOGENOUS ALLERGIC ALVEOLITISV. B. Nefedov0L. A. Popova1E. A. Shergina2N. N. Makaryants3ФГБУ «Центральный НИИ туберкулеза» РАМН, г. МоскваФГБУ «Центральный НИИ туберкулеза» РАМН, г. МоскваФГБУ «Центральный НИИ туберкулеза» РАМН, г. МоскваФГБУ «Центральный НИИ туберкулеза» РАМН, г. МоскваTotal lung capacity (TLC), lung capacity (LC), forced LC (FLC), intrathoracic volume (ITV), pulmonary residual volume (PRV), forced expiratory volume in one second (FEV1 ), (FEV1 )/LC%, peak expiratory flow (PEF), maximum expiratory flow rate (MEFR)25, MEFR50, MEFR75, Raw, Rin, Rex, DLCO-SB, DLCO-SB/VА, РаО2 , and РаСО2 were determined in 43 patients with exogenous allergic alveolitis (EAA) before, during, and after treatment with glucocorticosteroids, hemapheresis, ambroxol, and fluimucil. Lung function became better in more than half (53.5%) of the patients and worse in one fourth (25.6%); a combination of positive and negative functional changes was detected in 14.0%. Improved lung function was noted in 75.0, 50.0, and 38.5% of the patients with acute, subacute, and chronic EAA, respectively. Deterioration of lung function was determined in 46.2, 22.2, and 8.3% of the patients with chronic, subacute, and acute alveolitis, respectively. Better lung function manifested itself mainly as positive changes in lung volumes and capacities and pulmonary gas exchange function, less frequently as improved bronchial patency in the patients with acute and subacute EAA whereas the rate of positive functional changes in lung volumes and capacities, bronchial patency, and pulmonary gas exchange function was equal in those with chronic EAA. Poorer lung function appeared as negative changes in lung volumes and capacities in the patients with acute EAA, as worse pulmonary gas exchange function and negative changes in lung volumes and capacities and deteriorated bronchial patency in those with subacute and chronic EAA.https://www.tibl-journal.com/jour/article/view/291lung functionexogenous allergic alveolitis
spellingShingle V. B. Nefedov
L. A. Popova
E. A. Shergina
N. N. Makaryants
CHANGES IN LUNG FUNCTION IN THE TREATMENT OF PATIENTS WITH EXOGENOUS ALLERGIC ALVEOLITIS
Туберкулез и болезни лёгких
lung function
exogenous allergic alveolitis
title CHANGES IN LUNG FUNCTION IN THE TREATMENT OF PATIENTS WITH EXOGENOUS ALLERGIC ALVEOLITIS
title_full CHANGES IN LUNG FUNCTION IN THE TREATMENT OF PATIENTS WITH EXOGENOUS ALLERGIC ALVEOLITIS
title_fullStr CHANGES IN LUNG FUNCTION IN THE TREATMENT OF PATIENTS WITH EXOGENOUS ALLERGIC ALVEOLITIS
title_full_unstemmed CHANGES IN LUNG FUNCTION IN THE TREATMENT OF PATIENTS WITH EXOGENOUS ALLERGIC ALVEOLITIS
title_short CHANGES IN LUNG FUNCTION IN THE TREATMENT OF PATIENTS WITH EXOGENOUS ALLERGIC ALVEOLITIS
title_sort changes in lung function in the treatment of patients with exogenous allergic alveolitis
topic lung function
exogenous allergic alveolitis
url https://www.tibl-journal.com/jour/article/view/291
work_keys_str_mv AT vbnefedov changesinlungfunctioninthetreatmentofpatientswithexogenousallergicalveolitis
AT lapopova changesinlungfunctioninthetreatmentofpatientswithexogenousallergicalveolitis
AT eashergina changesinlungfunctioninthetreatmentofpatientswithexogenousallergicalveolitis
AT nnmakaryants changesinlungfunctioninthetreatmentofpatientswithexogenousallergicalveolitis